Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Stepan Podzimek

Stepan Podzimek

General University Hospital in Prague & Charles University, Czech Republic

Title: Periopathogenic bacteria in patients undergoing implantation therapy in Dentistry

Biography

Biography: Stepan Podzimek

Abstract

Aim of the study: The purpose of the study was to compare presence of periopathogenic bacteria in sites intended for implantation therapy in dentistry with success of this therapy.

Material and methods: Fifty-four patients underwent implantation therapy by titanium implants from BTLock company (Italy). Before dental implantation therapy started, saliva samples from implantation site were collected. From these samples, microbial DNA was isolated by DNeasy Blood & Tissue Kit (QIAGEN). Presence of periopathogenic bacteria Tannerella forsythensis, Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens, Aggregatibacter actinomycetemcomitans and Capnocytophaga ochracea was determined by qualitative PCR using periopathogenic bacteria specific primers.

Results: Prevotella nigrescens was found in 64.3 % of patients, Prevotella intermedia was found in 28.6 % of patients, Tannerella forsythensis was found in 25 % of patients, Porphyromonas gingivalis was found in 14.3 % of patients, Capnocytophaga ochracea was found in 12.5 % of patients and Aggregatibacter actinomycetemcomitans was found in 1.8 % of patients. Implantation therapy was successful in all patients.

Conclusion: Presence of periopathogenic bacteria in implantation sites was common in patients undergoing implantation therapy. Despite this fact, there was no problem with implant healing and implantation therapy was successful in all patients.

Acknowledgement: This study was supported by projects nr. NV19-08-00070 and 17-30753A (Ministry of Health, Czech Republic) and by project PROGRES Q29/1LF (First Faculty of Medicine, Charles University, Czech Republic).

Recent Publications

   1. Mysak J et al. Porphyromonas gingivalis: Major Periodontopathic Pathogen Overview. J Immunol Res. 2014;2014:476068. [IF- 3,298] (citations -68).

   2. Bartova J et al. Periodontitis as a Risk Factor of Atherosclerosis. J Immunol Res. 2014;2014:636893. [IF- 3,298] (citations -30).

  3. Belohlavek J et al. Severe allergic dermatitis after closure of foramen ovale with Amplatzer occluder. Ann Thorac Surg. 2013 Sep;96(3):e57-9. [IF-3,780] (citations -12).

 4. Podzimek S et al. Salivary markers for periodontal and general diseases. Disease Markers. 2016;2016:9179632. [IF- 2,949] (citations -11).

 5. Bartova J et al. The effect of IL-4 gene polymorphisms on cytokine production in patients with chronic periodontitis and in healthy controls. Mediators Inflamm. 2014;2014:185757.  [IF- 3,549] (citations -10).